End-expiratory Pressure During Laparoscopic Surgery in the Trendelenburg Position by Electrical Impedance Tomography
CP-EIT
Positive End-expiratory Pressure Titration During Laparoscopic Gynecological Surgery in the Trendelenburg Position Based on Ventilation and Perfusion Measured by Electrical Impedance Tomography: the CP-EIT Observational Study
1 other identifier
observational
50
1 country
1
Brief Summary
Pneumoperitoneum (PNP) and the position of the patient required for laparoscopic surgery lead to pathophysiological changes that complicate anesthesia. PNP is characterized by an increased intra-abdominal pressure (IAP), the cranial displacement of the diaphragm that can lead to the formation of intraoperative atelectasis and decrease end-expiratory lung volume (EELV). At the same time, PNP can reduce respiratory system compliance by 30-50% in healthy patients. During elective abdominal surgery under general anesthesia, atelectasis forms in almost 90% of patients and can become a focus of postoperative pneumonia. The negative effect of PNP is more prominent in Trendelenburg position. And one of the methods to avoid the effects of PNP and Trendelenburg position on lung tissue is to apply positive end-expiratory pressure (PEEP). PEEP is acknowledged as a component of lung protective ventilation (LPV) along with low tidal volume (TV) 6-8 ml/kg. On the other hand, excessive PEEP can lead to the overdistension of lung tissue and cause volutrauma and hemodynamic instability. It is necessary to use sufficient PEEP to minimize atelectasis, improve respiratory biomechanics and maintain oxygenation. Electrical impedance tomography shows changes in ventilation and perfusion during mechanical ventilation with the different PEEP levels. The study aimed to select optimum PEEP level based on optimum ventilation-to-perfusion match based on electrical impedance tomography measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2024
CompletedStudy Start
First participant enrolled
June 24, 2024
CompletedFirst Posted
Study publicly available on registry
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMay 2, 2025
June 1, 2024
5 months
June 18, 2024
April 29, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Optimum positive end-expiratory pressure level by compliance win
Positive end-expiratory pressure level selected by maximal compliance win measured by electrical impedance tomography
40 minutes
Optimum positive end-expiratory pressure level by heart-lung index
Positive end-expiratory pressure level selected by maximal heart-lung index measured by electrical impedance tomography
40 minutes
Secondary Outcomes (10)
Compliance win
3 minutes
Compliance loss
3 minutes
Global inhomogeneity index
3 minutes
Regional ventilation delay
3 minutes
Lung-heart index
3 minutes
- +5 more secondary outcomes
Interventions
Measurement of ventilation and perfusion during mechanical ventilation with different positive end-expiratory pressure by electrical impedance tomography
Eligibility Criteria
Patients who underwent elective gynecological operations in conditions of carboxyperitoneum with Trendelenburg position
You may qualify if:
- Patients who undergo gynecological surgery under conditions of carboxyperitoneum in the Trendelenburg position.
You may not qualify if:
- Pregnancy,
- Hypoxemia before surgery (SpO2 \< 94%),
- body mass index more than 35 kg/m2,
- Unstable hemodynamics and/or life-threatening arrhythmia,
- Primary or secondary lung diseases (COPD, interstitial lung diseases, metastatic lung disease)
- Presence of an implantable pacemaker and/or defibrillator
- Chronic diseases in the stage of decompensation with the development of extrapulmonary organ dysfunction (liver cirrhosis, progression of cancer, chronic heart failure).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Hospital 4, Sechenov University
Moscow, 119048, Russia
Related Publications (5)
Andersson LE, Baath M, Thorne A, Aspelin P, Odeberg-Wernerman S. Effect of carbon dioxide pneumoperitoneum on development of atelectasis during anesthesia, examined by spiral computed tomography. Anesthesiology. 2005 Feb;102(2):293-9. doi: 10.1097/00000542-200502000-00009.
PMID: 15681942BACKGROUNDLoring SH, Behazin N, Novero A, Novack V, Jones SB, O'Donnell CR, Talmor DS. Respiratory mechanical effects of surgical pneumoperitoneum in humans. J Appl Physiol (1985). 2014 Nov 1;117(9):1074-9. doi: 10.1152/japplphysiol.00552.2014. Epub 2014 Sep 11.
PMID: 25213641BACKGROUNDBarbosa FT, Castro AA, de Sousa-Rodrigues CF. Positive end-expiratory pressure (PEEP) during anaesthesia for prevention of mortality and postoperative pulmonary complications. Cochrane Database Syst Rev. 2014 Jun 12;2014(6):CD007922. doi: 10.1002/14651858.CD007922.pub3.
PMID: 24919591BACKGROUNDSlutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013 Nov 28;369(22):2126-36. doi: 10.1056/NEJMra1208707. No abstract available.
PMID: 24283226BACKGROUNDFahy BG, Barnas GM, Nagle SE, Flowers JL, Njoku MJ, Agarwal M. Changes in lung and chest wall properties with abdominal insufflation of carbon dioxide are immediately reversible. Anesth Analg. 1996 Mar;82(3):501-5. doi: 10.1097/00000539-199603000-00013.
PMID: 8623951BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrey I Yaroshetskiy, MD, PhD, ScD
Sechenov University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2024
First Posted
July 1, 2024
Study Start
June 24, 2024
Primary Completion
December 1, 2024
Study Completion
December 31, 2024
Last Updated
May 2, 2025
Record last verified: 2024-06